These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9013374)

  • 41. Enhanced diltiazem bioavailability after oral administration of diltiazem with quercetin to rabbits.
    Choi JS; Li X
    Int J Pharm; 2005 Jun; 297(1-2):1-8. PubMed ID: 15907592
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effects of encainide versus diltiazem on the oxidative metabolic pathways of antipyrine.
    Bottorff MB; Lalonde RL; Kazierad DJ; Hoon TJ; Tsiu SJ; Mirvis DM
    Pharmacotherapy; 1989; 9(5):315-21. PubMed ID: 2510135
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacokinetic and safety profile of rupatadine when coadministered with azithromycin at steady-state levels: a randomized, open-label, two-way, crossover, Phase I study.
    Solans A; Izquierdo I; Donado E; Antonijoan R; Peña J; Nadal T; Carbó ML; Merlos M; Barbanoj M
    Clin Ther; 2008 Sep; 30(9):1639-50. PubMed ID: 18840369
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Single oral dose pharmacokinetic interaction study of manidipine and delapril in healthy volunteers.
    Stockis A; Gengler C; Goethals F; Jeanbaptiste B; Lens S; Poli G; Acerbi D
    Arzneimittelforschung; 2003; 53(9):627-34. PubMed ID: 14558436
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacokinetics of diltiazem and its major metabolite, deacetyidiltiazem after oral administration of diltiazem in mild and medium folate-induced renal failure rabbits.
    Choi JS; Lee JH; Burm JP
    Arch Pharm Res; 2001 Aug; 24(4):333-7. PubMed ID: 11534767
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacokinetic interaction of telmisartan with s-amlodipine: an open-label, two-period crossover study in healthy Korean male volunteers.
    Noh YH; Lim HS; Kim MJ; Kim YH; Choi HY; Sung HR; Jin SJ; Lim J; Bae KS
    Clin Ther; 2012 Jul; 34(7):1625-35. PubMed ID: 22721873
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Enhanced oral exposure of diltiazem by the concomitant use of naringin in rats.
    Choi JS; Han HK
    Int J Pharm; 2005 Nov; 305(1-2):122-8. PubMed ID: 16226412
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacodynamics and pharmacokinetics of clentiazem and diltiazem in closed-chest anesthetized dogs.
    Giasson S; Garceau D; Homsy W; Dumont L
    Cardiovasc Drugs Ther; 1995 Oct; 9(5):685-92. PubMed ID: 8573551
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diltiazem and mibefradil increase the plasma concentrations and greatly enhance the adrenal-suppressant effect of oral methylprednisolone.
    Varis T; Backman JT; Kivistö KT; Neuvonen PJ
    Clin Pharmacol Ther; 2000 Mar; 67(3):215-21. PubMed ID: 10741623
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of hesperidin on the oral pharmacokinetics of diltiazem and its main metabolite, desacetyldiltiazem, in rats.
    Cho YA; Choi DH; Choi JS
    J Pharm Pharmacol; 2009 Jun; 61(6):825-9. PubMed ID: 19505375
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical pharmacokinetics of mizolastine.
    Lebrun-Vignes B; Diquet B; Chosidow O
    Clin Pharmacokinet; 2001; 40(7):501-7. PubMed ID: 11510627
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of resveratrol on the pharmacokinetics of diltiazem and its major metabolite, desacetyldiltiazem, in rats.
    Hong SP; Choi DH; Choi JS
    Cardiovasc Ther; 2008; 26(4):269-75. PubMed ID: 19035878
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of ritonavir on the pharmacokinetics of ethinyl oestradiol in healthy female volunteers.
    Ouellet D; Hsu A; Qian J; Locke CS; Eason CJ; Cavanaugh JH; Leonard JM; Granneman GR
    Br J Clin Pharmacol; 1998 Aug; 46(2):111-6. PubMed ID: 9723818
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Assessment of the potential pharmacokinetic interaction between digoxin and ethmozine.
    MacFarland RT; Moeller VR; Pieniaszek HJ; Whitney CC; Marcus FI
    J Clin Pharmacol; 1985 Mar; 25(2):138-43. PubMed ID: 3886709
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Single and multiple oral dose pharmacokinetics of clentiazem in normal volunteers.
    Bhargava VO; Shah AK; Weir SJ; Nordbrock EE; Giesing DH
    J Clin Pharmacol; 1993 May; 33(5):439-43. PubMed ID: 8331200
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effect of hepatic disease on the disposition of moricizine in humans.
    Pieniaszek HJ; Davidson AF; McEntegart CM; Quon CY; Sampliner RE; Mayersohn M
    Biopharm Drug Dispos; 1994 Apr; 15(3):243-52. PubMed ID: 7880984
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical pharmacokinetics of moricizine.
    Siddoway LA; Schwartz SL; Barbey JT; Woosley RL
    Am J Cardiol; 1990 Feb; 65(8):21D-25D; discussion 68D-71D. PubMed ID: 2407090
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of phenobarbital pretreatment on the pharmacokinetics and metabolism of diltiazem in rats.
    Yeung PK; Buckley SJ; Cameron R; Feng JD; Jordan J
    Drug Metabol Drug Interact; 1996; 13(1):29-39. PubMed ID: 8902429
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Moricizine: a new class I antiarrhythmic.
    Mann HJ
    Clin Pharm; 1990 Nov; 9(11):842-52. PubMed ID: 2272151
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The pharmacokinetics and pharmacodynamics of diltiazem and its metabolites in healthy adults after a single oral dose.
    Boyd RA; Chin SK; Don-Pedro O; Verotta D; Sheiner LB; Williams RL; Giacomini KM
    Clin Pharmacol Ther; 1989 Oct; 46(4):408-19. PubMed ID: 2791444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.